Skip to main content
PegBio Co., Ltd. logo

PegBio Co., Ltd. — Investor Relations & Filings

Ticker · 2565 ISIN · CNE100006T44 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 2,125 across all filing types
Latest filing 2018-10-18 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 2565

About PegBio Co., Ltd.

http://www.pegbio.com

PegBio Co., Ltd. is a biotechnology company specializing in the in-house discovery and development of innovative therapies for chronic diseases, primarily focusing on the endocrine and metabolic fields. The company leverages its proprietary HECTORTM technology system to design and screen novel molecular entities, including peptide, protein, and small-molecule drugs, targeting unmet clinical needs. PegBio's robust pipeline addresses major chronic conditions such as Type 2 Diabetes (T2DM), obesity, and metabolic dysfunction-associated steatohepatitis (MASH). Key pipeline assets include long-acting GLP-1 receptor agonists, such as Vepinatide, developed for T2DM treatment and weight management. The company emphasizes creating complementary, multi-benefit product pipelines characterized by new targets, new sites, and new mechanisms of action.

Recent filings

Filing Released Lang Actions
SUPPLEMENTAL ANNOUNCEMENT - DISCLOSEABLE TRANSACTION IN RELATION TO PROVISION OF FINANCIAL ASSISTANCE
Capital/Financing Update Classification · 95% confidence The document is titled as a "SUPPLEMENTAL ANNOUNCEMENT DISCLOSEABLE TRANSACTION IN RELATION TO PROVISION OF FINANCIAL ASSISTANCE" and references a prior announcement dated 17 August 2018. It provides additional details about a financial assistance transaction, specifically about a shortfall recovery arrangement and charged assets. The document is relatively short (4117 characters) and is clearly an announcement providing supplemental information to a previous disclosure. It does not contain financial statements, detailed financial analysis, or management discussion. It is not a full report but an announcement related to a capital or financing transaction. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2018-10-18 English
NEXT DAY DISCLOSURE RETURN - CHANGE IN ISSUED SHARE CAPITAL
Transaction in Own Shares Classification · 95% confidence The document is a disclosure return filed by a listed issuer regarding changes in issued share capital and share buybacks. It includes detailed information about the number of shares issued, issue prices, and confirmation of compliance with listing rules. The document is structured as a regulatory disclosure form submitted to the stock exchange, specifically referencing rules governing share capital changes and repurchases. It does not contain financial statements, management discussion, or earnings data, nor is it a report or presentation. It is a regulatory announcement about share capital changes and share repurchases, fitting the category of Transaction in Own Shares (POS). The document length is 7422 characters, which is sufficient for a detailed disclosure rather than a brief announcement. Therefore, the appropriate classification is POS.
2018-10-15 English
COMPLETION OF CONNECTED TRANSACTION IN RELATION TO SUBSCRIPTION OF NEW SHARES UNDER SPECIFIC MANDATE
Capital/Financing Update Classification · 95% confidence The document is an announcement from CMBC Capital Holdings Limited regarding the completion of a connected transaction involving the subscription of new shares under a specific mandate. It details the subscription completion date, the number of shares subscribed, the subscription price, changes in shareholding structure, and intended use of proceeds. The document is not a full financial report but an update on a capital raising event and share issuance. It is longer than 5,000 characters and contains substantive details about the transaction. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. It is not an announcement of a report publication, nor a regulatory filing or other categories. Therefore, the correct classification is CAP with high confidence.
2018-10-15 English
EXTENSION OF LONG STOP DATE RELATING TO THE CONNECTED TRANSACTION
Capital/Financing Update Classification · 95% confidence The document is an announcement from CMBC Capital Holdings Limited regarding the extension of the long stop date related to a connected transaction involving subscription shares. It references previous announcements and circulars but does not contain financial statements or detailed financial data. The content focuses on an update about a financing transaction timeline rather than a full report or detailed financial disclosure. The document length is short (2314 characters), and it serves as an update on capital/financing activities. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2018-10-05 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2018
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly report on movements in the issuer's share capital, including authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related movements. It is addressed to the Hong Kong Exchanges and Clearing Limited and includes specific data for the month ended 30/09/2018. The content focuses on share capital changes and related corporate actions rather than financial performance, earnings, or management commentary. It is not an announcement of a report but a substantive regulatory filing about share capital movements. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes.
2018-10-04 English
DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE PROVISION OF ADVISORY SERVICES
Regulatory Filings Classification · 95% confidence The document is an announcement from CMBC Capital Holdings Limited regarding a discloseable and connected transaction related to the provision of advisory services. It details the terms of an Advisory Agreement, the parties involved, the fees, and the implications under the Hong Kong Listing Rules. The document includes definitions, background information, and regulatory compliance statements. It is a formal announcement of a transaction rather than a financial report, earnings release, or management discussion. There is no financial statement or detailed financial analysis present. The document is lengthy (15,000 characters) but is clearly an announcement of a transaction subject to regulatory reporting requirements under the Listing Rules. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2018-10-01 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.